FEDERATED HERMES, INC. - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$4,580,000
-68.9%
227,187
-42.4%
0.01%
-66.7%
Q2 2021$14,715,000
+172.1%
394,301
+86.5%
0.03%
+170.0%
Q1 2021$5,407,000
+90016.7%
211,478
+78225.2%
0.01%
Q4 2020$6,000
-99.7%
270
-99.8%
0.00%
-100.0%
Q3 2020$1,948,000
-35.2%
108,260
-8.6%
0.01%
-28.6%
Q2 2020$3,007,000
+4.5%
118,396
-24.4%
0.01%
-12.5%
Q1 2020$2,877,000
-64.0%
156,605
-56.8%
0.01%
-55.6%
Q4 2019$7,991,000
+316.0%
362,716
+171.1%
0.02%
+260.0%
Q3 2019$1,921,000
-54.5%
133,787
-53.5%
0.01%
-50.0%
Q1 2019$4,219,000
+19.0%
287,961
-13.1%
0.01%0.0%
Q4 2018$3,544,000
-8.0%
331,553
+31.3%
0.01%
+11.1%
Q3 2018$3,853,000
+76960.0%
252,495
+61484.1%
0.01%
Q2 2018$5,000
+150.0%
410
-24.2%
0.00%
Q2 2017$2,000
-60.0%
541
-64.9%
0.00%
Q1 2017$5,000
+25.0%
1,5410.0%0.00%
Q4 2016$4,000
+300.0%
1,541
+610.1%
0.00%
Q3 2016$1,0000.0%217
+223.9%
0.00%
Q2 2015$1,000
-87.5%
67
-79.8%
0.00%
Q1 2015$8,0003310.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,355,392$29,859,0006.21%
Bain Capital Life Sciences Investors, LLC 3,080,237$67,858,0004.26%
DAFNA Capital Management LLC 587,756$12,948,0003.85%
SILVERARC CAPITAL MANAGEMENT, LLC 227,388$5,009,0002.91%
RTW INVESTMENTS, LP 7,253,857$159,802,0002.68%
Parkman Healthcare Partners LLC 331,513$7,303,0001.87%
Evolutionary Tree Capital Management, LLC 60,864$1,341,0001.02%
Eagle Health Investments LP 69,000$1,520,0000.97%
Woodline Partners LP 1,358,796$29,934,0000.79%
Affinity Asset Advisors, LLC 40,000$881,0000.47%
View complete list of DICERNA PHARMACEUTICALS INC shareholders